Role of markers C-Reactive Protein, Procalcitonin and TREM-1 in diagnosis of infection pleural effusion

V. Alvarenga (Sao Paulo, Brazil), M. Acencio (Sao Paulo, Brazil), R. Sales (Sao Paulo, Brazil), A. Silva (Sao Paulo, Brazil), J. Silva (Sao Paulo, Brazil), C. Silva (Sao Paulo, Brazil), L. Ribeiro Teixeira (Sao Paulo, Brazil), E. Marchi (Sao Paulo, Brazil)

Source: International Congress 2018 – Mesothelioma and pleural malignancy: investigations and management
Session: Mesothelioma and pleural malignancy: investigations and management
Session type: Thematic Poster
Number: 2863
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Alvarenga (Sao Paulo, Brazil), M. Acencio (Sao Paulo, Brazil), R. Sales (Sao Paulo, Brazil), A. Silva (Sao Paulo, Brazil), J. Silva (Sao Paulo, Brazil), C. Silva (Sao Paulo, Brazil), L. Ribeiro Teixeira (Sao Paulo, Brazil), E. Marchi (Sao Paulo, Brazil). Role of markers C-Reactive Protein, Procalcitonin and TREM-1 in diagnosis of infection pleural effusion. 2863

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Biomarkers of infection for the differential diagnosis of pleural effusions
Source: Eur Respir J 2009; 34: 1383-1389
Year: 2009



Procalcitonin and CRP levels in pleural effusions
Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience
Year: 2009

Serum procalcitonin as a potential biomarker of surgery in parapneumonic pleural effusions
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016


Diagnostic value of procalcitonin and C-reactive protein in the differentiation among bening and malignant pleural effusion
Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience
Year: 2009


Serum Procalcitonin for diagnosing and monitoring response in pleural infection
Source: International Congress 2019 – Pleural infection and complicated pneumonia
Year: 2019


Usefulness of procalcitonin as a diagnostic marker of pleural effusion
Source: Annual Congress 2012 - Prognostic indices in respiratory infections
Year: 2012

Expression of YKL-40 and MIP-1a proteins in exudates and transudates: Biomarkers for differential diagnosis of pleural effusions?
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014


Pleural fluid procalcitonin levels in identifying pleural effusions due to infection
Source: Annual Congress 2009 - Aetiology and diagnosis of lower respiratory tract infections
Year: 2009


Usefulness of pleural fluid C-reactive protein in differentiation of pleural effusions
Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience
Year: 2009

Usefulness of pleural fluid C-reactive protein in differentiation of pleural effusions
Source: Annual Congress 2010 - From rare towards common lung diseases: diagnostic and monitoring challenges
Year: 2010

The use of pleural fluid C-reactive protein level, as a diagnostic marker for pleural effusions
Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience
Year: 2009


Diagnostic value of C-reactive protein in discrimination between complicated and uncomplicated parapneumonic effusion
Source: International Congress 2019 – Clinical problems
Year: 2019


Diagnostic value of C-reactive protein in exudative pleural effusions
Source: International Congress 2019 – Clinical problems
Year: 2019


The implication of C-reactive protein in differentiation of various pleural effusion etiologies
Source: Annual Congress 2008 - Community-acquired pneumonia: prognosis, complications and prevention
Year: 2008


Evaluation of pleural fluid total protein, albumin, globulin levels and albumin/globulin ratios in the differential diagnosis of pleural effusions
Source: International Congress 2016 – From pleura to bronchi: new insights
Year: 2016


Rapid evaluation of exudative pleural effusion using C-reactive protein
Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience
Year: 2009


Serum C-reactive protein levels predict the need for surgical intervention in patients with empyema/complicated parapneumonic pleural effusions
Source: International Congress 2019 – Pleural infection and complicated pneumonia
Year: 2019

Pleural fluid C-reactive protein concentration in discriminating uncomplicated from complicated parapneumonic pleural effusion
Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections
Year: 2012

Usefulness of C-reactive protein and procalcitonin levels in pulmonary tuberculosis
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 3
Year: 2014


Role of C-reactive protein in discriminating complicated and uncomplicated parapneumonic effusion from malignant and tuberculous pleural effusion
Source: Virtual Congress 2021 – Clinical problems associated with cough, pleura and respiratory health status
Year: 2021